Format

Send to

Choose Destination
BMC Cancer. 2015 Jul 5;15:500. doi: 10.1186/s12885-015-1497-1.

Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information.

Author information

1
Speciality Registrar in Public Health, NHS England, South Plaza, Marlborough Street, Bristol, BS1 3NX, UK. Rebecca.maclean1@nhs.net.
2
Senior Lecturer in Epidemiology, School for Social and Community Medicine, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. mona.jeffreys@bris.ac.uk.
3
Senior Analyst, Public Health England Knowledge and Intelligence team (South West), 1st floor, Grosvenor House, 149 Whiteladies Road, Bristol, BS8 2RA, UK. Alex.ives@phe.gov.uk.
4
Research Assistant, NIHR CLAHRC West, 9th Floor, Whitefriars, Lewins Mead, Bristol, BS1 2NT, UK. timonthy.jones@bris.ac.uk.
5
Public Health England Knowledge and Intelligence team (South West), 1st floor, Grosvenor House, 149 Whiteladies Road, Bristol, BS8 2RA, UK. Julia.verne@phe.gov.uk.
6
School for Social and Community Medicine, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. Y.ben-shlomo@bris.ac.uk.

Abstract

BACKGROUND:

Survival from cancer is worse in England than in some European countries. To improve survival, strategies in England have focused on early presentation (reducing delay to improve stage at diagnosis), improving quality of care and ensuring equity throughout the patient pathway. We assessed whether primary care characteristics were associated with later stage cancer at diagnosis (stages 3/4 versus 1/2) for female breast, lung, colorectal and prostate cancer.

METHODS:

Data obtained from the National Cancer Registration Service, Quality Outcomes Framework, GP survey and GP workforce census, linked by practice code. Risk differences (RD) were calculated by primary care characteristics using a generalised linear model, accounting for patient clustering within practices. Models were adjusted for age, sex and an area-based deprivation measure.

RESULTS:

For female breast cancer, being with a practice with a higher two week wait (TWW) referral rate (RD -1.8% (95 % CI -0.5% to -3.2%) p = 0.003) and a higher TWW detection rate (RD -1.7% (95 % CI -0.3% to -3.0%) p = 0.003) was associated with a lower proportion diagnosed later. Being at a practice where people thought it less easy to book at appointment was associated with a higher percentage diagnosed later (RD 1.8% (95 % CI 0.2% to 3.4%) p = 0.03). For lung cancer, being at practices with higher TWW referral rates was associated with lower proportion advanced (RD-3.6% (95 % CI -1.8%, -5.5%) p < 0.001) whereas being at practices with more patients per GP was associated with higher proportion advanced (RD1.8% (95 % CI 0.2, 3.4) p = 0.01). A higher rate of gastrointestinal investigations was associated with a lower proportion of later stage colorectal cancers (RD -2.0% (95 % CI -0.6% to -3.6%) p = 0.01). No organisational characteristics were associated with prostate cancer stage.

CONCLUSION:

Easier access to primary care, faster referral and more investigation for gastrointestinal symptoms could reduce the proportion of people diagnosed later for female breast, lung and colorectal, but not prostate cancer. Differences between the four main cancers suggest different policies may be required for individual cancers to improve outcomes.

PMID:
26141458
PMCID:
PMC4491217
DOI:
10.1186/s12885-015-1497-1
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center